Industries > Pharma > Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis for Automation in Biopharma

PUBLISHED: 30 April 2020
PAGES: 142
PRODUCT CODE: PHA0455

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global automation in biopharma market forecasts from 2020-2030

• This report also breaks down the revenue forecast to 2030 for the global automation in biopharma market by applications & leading technology type:

• By Application:
• Global automation and digital market in biopharmaceutical industry in clinical stage
• Global automation and digital market in biopharmaceutical industry in drug discovery stage

• By Technology:

• Automation Technology
• DCS
• SCADA
• PLC
• MES
• HMI
• APC
• ERP
• LIMS
• CRM
• CAPA

• Digitization Technology
• IoT
• AI
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing

This report discusses the market trends and developments of each submarket.

• Our study discusses the selected leading companies that are the major players in the automation in biopharma market:
• PerkinElmer
• Thermo Fisher Scientific
• Sartorius
• Siemens
• Rockwell Automation
• & Other Companies

Visiongain’s study is intended for anyone requiring commercial analyses for the global automation in biopharma market. You find data, trends and predictions.

Buy our report today Automation in Biopharma Industry  Research 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030

    Download sample pages

    Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ